MedTrace Logo

Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome

NCT01263834 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2014-01-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the adjunctive effect of intratenon Bevacizumab on the result of trabeculectomy in primary term of intraocular pressure (IOP).

Conditions

Interventions

DRUG

Bevacizumab

Bevacizumab injection of 1.25m/0.05 cc + Mitomycin C soaked cellulose dose 0.4 mg/ml with 3 minutes of application

DRUG

Mitomycin C

Mitomycin C soaked cellulose dose 0.4 mg/ml with 3 minutes of application

Sponsors & Collaborators

  • Prince of Songkla University

    lead OTHER

Principal Investigators

  • Weerawat Kiddee, MD · Prince of Songkla University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01263834 on ClinicalTrials.gov